Update shared on26 Sep 2025
Fair value Decreased 2.19%Analysts have trimmed Azelis Group’s price target to €19.13, citing weaker Q2 earnings, a more conservative sector outlook, and increased market risk, partially offset by sustained strength in specialty testing.
Analyst Commentary
- Reduced earnings estimates following a weaker-than-expected Q2 report.
- Increasing caution on the staffing services segment within the European business services sector.
- Downward revisions in price targets reflecting more conservative outlooks for growth and profitability.
- Continued positivity toward Azelis’s specialty testing businesses, providing a partial offset to negative sentiment.
- Valuation adjustments in response to sector-wide reassessment and increased market risk aversion.
Valuation Changes
Summary of Valuation Changes for Azelis Group
- The Consensus Analyst Price Target has fallen slightly from €19.56 to €19.13.
- The Consensus Revenue Growth forecasts for Azelis Group has fallen slightly from 5.3% per annum to 5.1% per annum.
- The Discount Rate for Azelis Group has risen slightly from 8.98% to 9.20%.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.